These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20450647)

  • 21. Identification and validation of novel therapeutic targets for multiple myeloma.
    Hideshima T; Chauhan D; Richardson P; Anderson KC
    J Clin Oncol; 2005 Sep; 23(26):6345-50. PubMed ID: 16155018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recommendations for the cytogenetic management of multiple myeloma proposed by the French Group for Cytogenetic Hematology]].
    Groupe Français de Cytogénétique Hématologique (GFCH)
    Pathol Biol (Paris); 2004 Jun; 52(5):263-4. PubMed ID: 15217710
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.
    Rawstron A
    Haematologica; 2005 Jul; 90(7):867B. PubMed ID: 15996918
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic variations in multiple myeloma I: effect on risk of multiple myeloma.
    Vangsted A; Klausen TW; Vogel U
    Eur J Haematol; 2012 Jan; 88(1):8-30. PubMed ID: 21883480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro: allogeneic transplantation in multiple myeloma.
    Gahrton G
    Clin Adv Hematol Oncol; 2006 May; 4(5):388-91. PubMed ID: 16728947
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.
    Chang H; Qi XY; Samiee S; Yi QL; Chen C; Trudel S; Mikhael J; Reece D; Stewart AK
    Bone Marrow Transplant; 2005 Nov; 36(9):793-6. PubMed ID: 16113669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloma: classification and risk assessment.
    Fonseca R; Monge J
    Semin Oncol; 2013 Oct; 40(5):554-66. PubMed ID: 24135400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 29. Guest editorial: basic and clinical updates in multiple myeloma.
    Kizaki M
    Int J Hematol; 2013 Mar; 97(3):304-5. PubMed ID: 23420182
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic heterogeneity in multiple myeloma.
    Magrangeas F; Lodé L; Wuilleme S; Minvielle S; Avet-Loiseau H
    Leukemia; 2005 Feb; 19(2):191-4. PubMed ID: 15538406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to management of multiple myeloma.
    Hájek R; Vásová I; Adam Z; Mayer J
    Acta Med Austriaca; 1996; 23(3):91-8. PubMed ID: 8798282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloma bone disease: pathogenesis and treatment.
    Roodman GD;
    Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma: current perspectives.
    Slovak ML
    Clin Lab Med; 2011 Dec; 31(4):699-724, x. PubMed ID: 22118745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental therapeutics for multiple myeloma--a road map for the future.
    Shaughnessy JD; Barlogie B
    Semin Hematol; 2001 Jul; 38(3):295-7. PubMed ID: 11486318
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
    de Larrea CF; Navarro A; Tejero R; Tovar N; Díaz T; Cibeira MT; Rosiñol L; Ferrer G; Rovira M; Rozman M; Monzó M; Bladé J
    Clin Cancer Res; 2012 Jul; 18(13):3697-704. PubMed ID: 22539802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.
    Neben K; Jauch A; Bertsch U; Heiss C; Hielscher T; Seckinger A; Mors T; Müller NZ; Hillengass J; Raab MS; Ho AD; Hose D; Goldschmidt H
    Haematologica; 2010 Jul; 95(7):1150-7. PubMed ID: 20220069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.
    Wavre A; Baur AS; Betz M; Mühlematter D; Jotterand M; Zaman K; Ketterer N
    Neuro Oncol; 2007 Jul; 9(3):370-2. PubMed ID: 17522337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cure of multiple myeloma -- more hype, less reality.
    Hari P; Pasquini MC; Vesole DH
    Bone Marrow Transplant; 2006 Jan; 37(1):1-18. PubMed ID: 16258534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical case of the month. Weakness in an 88-year-old man. Multiple myeloma.
    Stellingworth M; Broussard A; Cataldo V; Morrissey JR; Lipscomb G; Lopez FA; Rigby P
    J La State Med Soc; 2003; 155(2):84-9; quiz 89-90, 119. PubMed ID: 12778991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current approach to diagnosis and management of acute renal failure in myeloma patients.
    Leung N; Behrens J
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):297-302. PubMed ID: 22920640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.